Cochrane · systematic review · CD007794
Management of drainage for malignant ascites in gynaecological cancer
Kietpeerakool, C, Rattanakanokchai, S, Jampathong, N, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library
Gynaecological, Neuro-oncology and Orphan CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
2
No studies
4
Included studies
NR
No studies 4 · 66.7%Ungraded 0 · 0%Very low 2 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Abdominal paracentesis and intraperitoneal infusion of catumaxomab compared with abdominal paracentesis alone for management of drainage for malignant ascites in gynaecological cancer
Population: women with malignant ascites
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
QoL Abdominal paracentesis and intraperitoneal infusion of catumaxomab vs abdominal paracentesis alone | no estimate extracted | 1 study · 245 participants | Very low Downgraded: risk of bias, imprecision |
Improvement of ascites‐related symptoms Abdominal paracentesis and intraperitoneal infusion of catumaxomab vs abdominal paracentesis alone | no estimate extracted | NR | No studies |
Adverse events Abdominal paracentesis and intraperitoneal infusion of catumaxomab vs abdominal paracentesis alone | no estimate extracted | 1 study · 157 participants | Very low Downgraded: risk of bias, imprecision |
Participant satisfaction Abdominal paracentesis and intraperitoneal infusion of catumaxomab vs abdominal paracentesis alone | no estimate extracted | NR | No studies |
Caregiver satisfaction Abdominal paracentesis and intraperitoneal infusion of catumaxomab vs abdominal paracentesis alone | no estimate extracted | NR | No studies |
Cost‐effectiveness Abdominal paracentesis and intraperitoneal infusion of catumaxomab vs abdominal paracentesis alone | no estimate extracted | NR | No studies |